• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: COVIDIEN PROTEGE EVERFLEX SELF-EXPANDING STENT SYSTEM STANDARD; STENTS, DRAINS AND DILATORS FOR THE BILIARY DUCTS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

COVIDIEN PROTEGE EVERFLEX SELF-EXPANDING STENT SYSTEM STANDARD; STENTS, DRAINS AND DILATORS FOR THE BILIARY DUCTS Back to Search Results
Model Number PRB35-06-040-080
Medical Device Problem Codes Detachment of Device or Device Component (2907); Difficult to Advance (2920)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 02/17/2023
Type of Reportable Event Malfunction
Additional Manufacturer Narrative
Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.
 
Event or Problem Description
A protege everflex self expanding stent was being used to treat a 20mm soft tissue lesion with 70% stenosis in the mid right tibial/popliteal trunk.There was severe tortuosity and moderate calcification.The artery diameter was 6mm.There were abnormalities reported in relation to anatomy, trans tibial retrograde fashion accessing the anterior tibial, the origin of the at was very torturous having difficulties tracking catheters.A 6fr non medtronic sheath and a non medtronic guidewire were used.No embolic protection was used.The  lesion was pre dilated with an evercross.The device was prepped as per the ifu with no issues identified.Resistance was encountered advancing the device, no excessive force was used.It was reported that the delivery system was difficult to remove following stent deployment. stent catheter was removed applied some force (by pulling it off the wire) in a way that the pin pull came apart remaining on the wire and losing wire access because of that reason.The physician had to regain wire access in order to post dilate the treated area but was able to be deployed but off the target lesion with like 5-7mm distally to the target lesion which after postdilation with a 5x80x135 evercross the angiographic result was satisfactory.The procedure was successfully completed.No patient injury or complications were reported.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PROTEGE EVERFLEX SELF-EXPANDING STENT SYSTEM STANDARD
Common Device Name
STENTS, DRAINS AND DILATORS FOR THE BILIARY DUCTS
Manufacturer (Section D)
COVIDIEN
4600 nathan lane north
plymouth MN 55442
Manufacturer (Section G)
COVIDIEN
4600 nathan lane north
plymouth MN 55442
Manufacturer Contact
alison sweeney
parkmore business park west
galway 
EI  
091708096
MDR Report Key16529846
Report Number2183870-2023-00076
Device Sequence Number11402296
Product Code FGE
UDI-Device Identifier00821684059876
UDI-Public00821684059876
Combination Product (Y/N)N
Initial Reporter StateNY
Initial Reporter CountryUS
PMA/510(K) Number
P110023
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2023
Serviced by Third Party (Y/N)N
Reporter Type Manufacturer
Report Source Health Professional,Company Representative
Initial Reporter Occupation Physician
Type of Report Initial
Report Date (Section B) 03/13/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date08/22/2025
Device Model NumberPRB35-06-040-080
Device Catalogue NumberPRB35-06-040-080
Device Lot NumberB435566
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 02/17/2023
Initial Report FDA Received Date03/13/2023
Date Device Manufactured08/23/2022
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Patient SexMale
-
-